BCL2 and carcinoma: Another study confirmed this observation in which AM expression increased from benign endometrium to endometrial intraepithelial neoplasia and type-1 adenocarcinoma, but Bcl-2 expression decreased in the transition from endometrial intraepithelial neoplasia to carcinoma [296].